Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B LIPTON

Showing results (931-940 of 1,306) with videos related to

Pageof 131
Sort By:
Cephalalgia : an International Journal of Headache|December 6, 2014
Objectively measured physical activity in obese women with and without migraineDale S Bond, J Graham Thomas, Kevin C O'Leary, et al.
The Clinical Neuropsychologist|March 25, 2021
Re-evaluation of psychometric evidence and update of normative data for the Test of Practical JudgmentCrystal G Guayara-Quinn, Caroline O Nester, Mindy J Katz, et al.
Expert Review of Neurotherapeutics|November 28, 2022
Toward the optimized assessment of clinical outcomes in studies of novel treatments for Alzheimer's diseaseRichard B Lipton, Lauren Podger, Walter F Stewart, et al.
Personality and Individual Differences|April 4, 2018
Neuroticism, rumination, negative affect, and sleep: Examining between- and within-person associationsDanica C Slavish, Martin J Sliwinski, Joshua M Smyth, et al.
Urology|May 30, 2001
Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based surveyJ N Liberman, T L Hunt, W F Stewart, et al.
Journal of Orofacial Pain|October 31, 2013
Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled studyDaniela A G Goncalves, Cinara M Camparis, José G Speciali, et al.
Neurology|November 17, 2022
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE TrialRichard B Lipton, Patricia Pozo-Rosich, Andrew M Blumenfeld, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Technology and Dementia PreconferenceAngel Garcia De La Garza, Carol A Derby, Cuiling Wang, et al.
Headache|April 5, 2021
Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene-related peptide-targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug-drug interaction studyAbhijeet Jakate, Andrew M Blumenfeld, Ramesh Boinpally, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsAngel Garcia De La Garza, Carol A Derby, Cuiling Wang, et al.
Pageof 131

Showing results (931-940 of 1,306) with videos related to

Sort By:
Pageof 131
Cephalalgia : an International Journal of Headache|December 6, 2014
Objectively measured physical activity in obese women with and without migraineDale S Bond, J Graham Thomas, Kevin C O'Leary, et al.
The Clinical Neuropsychologist|March 25, 2021
Re-evaluation of psychometric evidence and update of normative data for the Test of Practical JudgmentCrystal G Guayara-Quinn, Caroline O Nester, Mindy J Katz, et al.
Expert Review of Neurotherapeutics|November 28, 2022
Toward the optimized assessment of clinical outcomes in studies of novel treatments for Alzheimer's diseaseRichard B Lipton, Lauren Podger, Walter F Stewart, et al.
Personality and Individual Differences|April 4, 2018
Neuroticism, rumination, negative affect, and sleep: Examining between- and within-person associationsDanica C Slavish, Martin J Sliwinski, Joshua M Smyth, et al.
Urology|May 30, 2001
Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based surveyJ N Liberman, T L Hunt, W F Stewart, et al.
Journal of Orofacial Pain|October 31, 2013
Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled studyDaniela A G Goncalves, Cinara M Camparis, José G Speciali, et al.
Neurology|November 17, 2022
Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE TrialRichard B Lipton, Patricia Pozo-Rosich, Andrew M Blumenfeld, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Technology and Dementia PreconferenceAngel Garcia De La Garza, Carol A Derby, Cuiling Wang, et al.
Headache|April 5, 2021
Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene-related peptide-targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug-drug interaction studyAbhijeet Jakate, Andrew M Blumenfeld, Ramesh Boinpally, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsAngel Garcia De La Garza, Carol A Derby, Cuiling Wang, et al.
Pageof 131